Printer Friendly

Browse Cancer metastasis topic

Care and treatment subtopic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
United States : Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer. Oct 12, 2017 394
Janssen Biotech submits NDA with the US FDA for apalutamide for non-metastatic castration-resistant prostate cancer. Oct 12, 2017 240
Janssen Biotech submits NDA with the US FDA for apalutamide for non-metastatic castration-resistant prostate cancer. Oct 12, 2017 244
Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer. Oct 11, 2017 1322
Astellas and Seattle Genetics Initiate Pivotal Trial of Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer. Oct 10, 2017 1310
Susan G. Komen Launches Its First Crowdfunding Initiative To Support Metastatic Breast Cancer Research. Oct 3, 2017 1003
Adding radiation to chemotherapy may dramatically improve survival for advanced-stage NSCLC patients. Sep 24, 2017 1909
Germany : European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma. Sep 22, 2017 713
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma. Sep 21, 2017 4362
Oncolytics Biotech[R] Announces Successful End-of-Phase 2 Meeting with FDA for REOLYSIN[R] in Metastatic Breast Cancer. Sep 18, 2017 917
Janssen submits supplemental NDA to US FDA for ZYTIGA for metastatic prostate cancer based on data from LATITUDE trial. Sep 15, 2017 320
Janssen submits supplemental NDA to US FDA for ZYTIGA for metastatic prostate cancer based on data from LATITUDE trial. Sep 15, 2017 316
United States : Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. Sep 15, 2017 475
Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. Sep 14, 2017 2884
Data from Pfizer Study of Trastuzumab Biosimilar Demonstrates Equivalence in ORR for Patients with HER2-positive Metastatic Breast Cancer. Clinical report Sep 12, 2017 319
United States : Lilly Builds Upon Body of Clinical Evidence for CYRAMZA (ramucirumab) with Phase 3 RANGE Data Demonstrating Superior Progression-Free Survival in Advanced or Metastatic Urothelial Cancer. Clinical report Sep 11, 2017 486
Novartis Phase III study demonstrates adjuvant Tafinlar + Mekinist reduced the risk of disease recurrence by 53% in patients with resected BRAF V600 mutation-positive melanoma. Sep 10, 2017 3804
United States : CheckMate -214 Study Evaluating Opdivo in Combination with Yervoy Stopped Early for Demonstrating Overall Survival Benefit in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma. Sep 8, 2017 200
Thermal Ablation in the Management of Adrenal Metastasis Originating from Non-small Cell Lung Cancer: A 5-year Single-center Experience. Botsa, Evanthia; Thanou, Ioanna; Papatheodoropoulou, Aspasia; Thanos, Loukas Report Sep 1, 2017 3228
FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo's DS-8201 for HER2-Positive Metastatic Breast Cancer. Aug 29, 2017 1202
Daiichi Sankyo Initiates Pivotal Phase 2 Study of DS-8201 in Patients with HER2-Positive Metastatic Breast Cancer. Aug 29, 2017 1234
The Alliance Foundation Trials launches PATINA trial for metastatic breast cancer. Aug 24, 2017 235
The Alliance Foundation Trials launches PATINA trial for metastatic breast cancer. Aug 24, 2017 231
Immune therapy durable in melanoma brain metastases. Oakes, Kari Clinical report Aug 1, 2017 773
Ocular metastasis as initial presentation in breast cancer. Maliepaard, M.; Mesham, M.; Aleksic, Z.; Scholtz, R.; Edge, J. Clinical report Aug 1, 2017 1572
Astrazeneca's Phase III FLAURA trial shows strong result for Tagrisso in lung cancer. Jul 28, 2017 273
Astrazeneca's Phase III FLAURA trial shows strong result for Tagrisso in lung cancer. Jul 28, 2017 277
Germany,United States : EMAs CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma. Jul 22, 2017 592
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma. Jul 21, 2017 4050
CTC4BMP: Circulating tumor cells for tailoring BMP targeted therapies. Jul 7, 2017 234
New Analysis Reveals First-Line Treatment Data on SIR-Spheres Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer. Jul 3, 2017 2390
New Analysis Reveals First-Line Treatment Data on SIR-Spheres Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer. Jul 3, 2017 2396
Predictive value of stathmin-1 and osteopontin expression for taxan resistance in metastatic castrate-resistant prostate cancer. Report Jun 30, 2017 3527
IsoRay Announces Study Published in The International Journal of Radiation Oncology, Biology, Physics entitled, "Clinical Outcomes of Large Brain Metastases Treated with Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial". Jun 20, 2017 889
United States : Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide in Patients with Non-metastatic Castration-Resistant Prostate Cancer. Clinical report Jun 10, 2017 337
Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide in Patients with Non-metastatic Castration-Resistant Prostate Cancer. Clinical report Jun 9, 2017 2325
Q BioMed Inc Announces Commercialization of Non-Narcotic Metastatic Cancer Pain Drug. Jun 7, 2017 1250
United States : Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrated Promising Activity in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer in Phase 2 CheckMate -142 Study. Jun 5, 2017 433
United States : Lynparza significantly reduces the risk of disease worsening or death in patients with BRCA-mutated metastatic breast cancer. Jun 5, 2017 520
Blueprint Medicines Announces New Phase 1 Clinical Data for BLU-285 in Advanced Gastrointestinal Stromal Tumors and Plans to Pursue Expedited Development in Patients with a PDGFR[eth] D842V Mutation. Jun 5, 2017 3266
Astellas and Seattle Genetics Announce Updated Enfortumab Vedotin Phase 1 Data in Metastatic Urothelial Cancer at 2017 ASCO Annual Meeting. Jun 5, 2017 1720
Abiraterone Acetate Provided Significant Clinical Benefit in Patients with High-Risk Metastatic Hormone-NaE[macron]ve Prostate Cancer (mHNPC), Improving Overall Survival and Radiographic Progression-Free Survival. Jun 3, 2017 2922
Cancer. Jun 1, 2017 167
Liver transplantation for non-resectable colorectal liver metastases at a single centre in South Africa: a report of the ethics and regulatory approval process. Etheredge, H.R.; Botha, J.; Cleaton-Jones, P. Report Jun 1, 2017 1775
New research in kidney cancer, ASCO-GU 2017. Basappa, Naveen; Pouliot, Frederic Jun 1, 2017 1491
Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival. Clinical report May 31, 2017 4616
Innovative Patient Registry to Provide Important Insights into the "Real World" Management of Metastatic Colorectal Cancer. Disease/Disorder overview May 30, 2017 739
Metastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows. May 24, 2017 1095
Metastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows. May 24, 2017 1101
Pigmented skin lesions lightened during immunotherapy. Smith, Jennie May 1, 2017 363
QUAD SHOT - HYPOFRACTIONATED RADIOTHERAPY FOR PALLIATION IN ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK. Report Apr 30, 2017 1947
Expression of CD133, E-cadherin and WWOX in colorectal cancer and related analysis. Apr 30, 2017 2845
United States : Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab) for the Treatment of Patients with Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma, a Type of Bladder Cancer. Apr 25, 2017 829
AbbVie Announces Topline Results from Two Phase 3 Studies Investigating Veliparib in Combination with Chemotherapy for the Treatment of Patients with Advanced or Metastatic Squamous Non-Small Cell Lung Cancer and Early-Stage Triple-Negative Breast Cancer. Apr 19, 2017 1207
AUA, ASCO, ASTRO and SUO Announce New Practice Guideline For Treatment Of Non-Metastatic Muscle-Invasive Bladder Cancer. Apr 13, 2017 507
Bristol-Myers Squibb submits sBLA with US FDA to extend the use of Opdivo in patients with dMMR or MSI-H metastatic colorectal cancer. Apr 5, 2017 270
Bristol-Myers Squibb submits sBLA with US FDA to extend the use of Opdivo in patients with dMMR or MSI-H metastatic colorectal cancer. Apr 5, 2017 266
NICE recommends Merck's Erbitux for patients with metastatic colorectal cancer. Mar 3, 2017 216
NICE recommends Merck's Erbitux for patients with metastatic colorectal cancer. Mar 3, 2017 212
Metastatic thymoma in a scarlet macaw (Ara macao). Lang, Barbara; Vorbruggen, Susanne; Kothe, Ruth; Britsch, Gerd; Schmidt, Volker Report Mar 1, 2017 3245
EMD Serono's BLA for avelumab accepted by US FDA for the treatment of patients with locally advanced or metastatic urothelial carcinoma. Mar 1, 2017 290
EMD Serono's BLA for avelumab accepted by US FDA for the treatment of patients with locally advanced or metastatic urothelial carcinoma. Mar 1, 2017 286
Rexahn Pharmaceuticals begins treatment under Phase IIa trial of Supinoxin in metastatic TNBC negative breast cancer patients. Clinical report Feb 24, 2017 277
Rexahn Pharmaceuticals begins treatment under Phase IIa trial of Supinoxin in metastatic TNBC negative breast cancer patients. Clinical report Feb 24, 2017 273
Novartis drug Zykadia granted FDA Priority Review. Feb 24, 2017 256
Novartis drug Zykadia granted FDA Priority Review. Feb 24, 2017 252
FDA Accepts Two sBLAs for US Merck's Keytruda for Locally Advanced or Metastatic Urothelial Cancer. Feb 3, 2017 473
EC Approves US Merck's Keytruda for First-Line Treatment of Metastatic Non-Small Cell Lung Cancer When Tumors Have High PD-L1 Expression with No EGFR or ALK Positive Tumor Mutations. Feb 1, 2017 332
Agilent Technologies Expands Dako PD-L1 IHC 22C3 PharmDx Companion Diagnostics. Feb 1, 2017 371
Adenocarcinoma of the cecum with rare splenic metastasis. Lucke-Wold, Brandon; Bonasso, Patrick C.; Turner, Ryan; Cassim, Riaz Clinical report Jan 1, 2017 1645
Prognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis. Dec 31, 2016 3904
Merck receives positive recommendation for KEYTRUDA for treating metastatic non-small cell lung cancer in adults. Dec 19, 2016 311
Merck receives positive recommendation for KEYTRUDA for treating metastatic non-small cell lung cancer in adults. Dec 19, 2016 307
CA thyroid with metastases. Kumar, Shishir; Chitnis, Ashuthosh; Kapoor, Priti; Palve, Rini; Vijay, Meeta Clinical report Dec 12, 2016 905
United States : PALOMA-2 Phase 3 Study Published in The New England Journal Of Medicine Demonstrates Clinical Benefit Of Pfizers IBRANCE (palbociclib) In First-Line ER+, HER2- Metastatic Breast Cancer. Nov 17, 2016 363
Eisai Welcomes Positive NICE recommendation for Halaven (eribulin) for Patients with Locally Advanced or Metastatic Breast Cancer. Nov 2, 2016 1350
Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutation. Erdogan, Bulent; Kodaz, Hilmi; Karabulut, Senem; Cinkaya, Ahmet; Tozkir, Hilmi; Tanriverdi, Ozgur; C Nov 1, 2016 4384
Celldex Therapeutics achieved positive results from a Phase II study of glembatumumab vedotin in patients with stage III/IV checkpoint inhibitor-refractory, and, if applicable, BRAF/MEK inhibitor-refractory metastatic melanoma (n=62). Clinical report Nov 1, 2016 268
OncoGenex Announces Positive Survival Results from Apatorsen Phase 2 Borealis-2(TM) Trial in Metastatic Bladder Cancer. Financial report Oct 25, 2016 923
First Patient in Malaysia Receives TheraSphere(TM) radioembolisation Therapy. Oct 19, 2016 1328
First Patient in Malaysia Receives TheraSphere(TM) radioembolisation Therapy. Oct 19, 2016 1333
Review Of Delcath's CHEMOSAT Accepted For Publication In Advances In Therapy. Oct 17, 2016 937
Delcath Announces First European Clinical Sites For FOCUS Phase 3 Trial For Ocular Melanoma Liver Metastases. Oct 12, 2016 1107
United States : New Retrospective Analyses Confirm Vectibix (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin. Oct 12, 2016 463
Final Results of NAPOLI-1 Study Confirm Overall Survival and Progression-Free Survival Benefit for the ONIVYDE Regimen for Patients with Metastatic Pancreatic Cancer. Oct 11, 2016 3602
Delcath Announces New U.S. Clinical Sites For FOCUS Phase 3 Trial For Ocular Melanoma Liver Metastases. Oct 11, 2016 1072
New Retrospective Analyses Confirm Vectibix (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin. Oct 10, 2016 6073
United States : Opdivo (nivolumab) stabilized patient-reported outcomes in patients with previously treated recurrent or metastatic squamous cell carcinoma of the head and neck in pivotal phase 3 checkmate. Oct 10, 2016 398
Phase III nintedanib trial results in patients with metastatic colorectal cancer announced at ESMO. Oct 9, 2016 1066
STEM-BCPC: Signal Transduction and Epigenetic Mechanisms of Breast Cell Plasticity and Cancer. Oct 7, 2016 401
Breast cancer metastasis to the thyroid gland. Goldenberg, Michael; Warrick, Joshua; Russo, Mariano; Bann, Darrin V. Report Oct 1, 2016 578
Melanoma to the heart. Durham, Charis G.; Hall, James A.; Fidone, Erica J.; Mack, Ryan; Metting, Austin L. Clinical report Oct 1, 2016 1036
The Prospective MOSCATO 01 Trial Demonstrates that Molecular "Portraits" Improve Outcome of Patients with Metastatic Cancer. Sep 22, 2016 819
The Prospective MOSCATO 01 Trial Demonstrates that Molecular "Portraits" Improve Outcome of Patients with Metastatic Cancer. Sep 22, 2016 824
Novartis survey published in The Breast Journal reveals major gaps in treatment discussions between metastatic breast cancer patients and doctors. Sep 14, 2016 1698
Eisai Bewildered as German Institute for Quality and Efficiency in Health Care (IQWIG) Fails to Recognise Additional Benefit of Halaven (eribulin) in the Treatment of Advanced Liposarcoma. Sep 4, 2016 1949
Merck and Pfizer have initiated a Phase III study, JAVELIN Ovarian 100, to evaluate the efficacy and safety of avelumab in combination with, and/or as follow-on (maintenance) treatment to, platinum-based chemotherapy in patients with locally advanced or metastatic disease (Stage III or Stage IV) with previously untreated epithelial ovarian cancer. Sep 1, 2016 189
Initial response of renal cell carcinoma to vemurafenib in a patient treated for metastatic melanoma. Hosier, Gregory W.; Roberts, Matthew T. Sep 1, 2016 1726
Adrenalectomy for solitary metastasis of Hepatocellular carcinoma post liver transplantation: Case report and literature review. Aug 31, 2016 1757
OncoGenex Announces Results from the Phase 3 AFFINITY Trial of Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer. Financial report Aug 16, 2016 1250
Switzerland : Novartis CDK4/6 inhibitor LEE011 (ribociclib) receives FDA Breakthrough Therapy designation as first-line treatment for HR+/HER2- advanced breast cancer. Aug 5, 2016 441
Vitamin C induces regression of pulmonary metastases. Gaby, Alan R. Brief article Aug 1, 2016 240
Circulating tumor cells: the root cause of cancer spreading. Connealy, Leigh Erin Aug 1, 2016 2302
Perforation of gastric cancer--what should the surgeon do? Ignjatovic, Nebojsa; Stojanov, Dragan; Djordjevic, Miodrag; Ignjatovic, Jelena; Stojanov, Daniela Be Aug 1, 2016 3428
Strategies to alleviate anxiety before the placement of a stereotactic radiosurgery frame. Avbovbo, Ufuoma E.; Appel, Susan J. Report Aug 1, 2016 3122
Diagnostic Performance of Urinary EGFR Testing in Lung Cancer Patients Published in Journal of Thoracic Oncology. Jul 26, 2016 1489
ONIVYDE Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Following Gemcitabine Based Therapy. Jul 25, 2016 2531
ONIVYDE Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Following Gemcitabine Based Therapy. Jul 25, 2016 2526
Outcomes Study On Delcath's Melphalan/HDS In The Treatment Of Hepatic Metastases To Be Published In Cancer Control. Jul 7, 2016 967
Elsevier Launches PracticeUpdate Metastatic Breast Cancer Center of Excellence. Jul 6, 2016 712
Elsevier Launches PracticeUpdate Metastatic Breast Cancer Center of Excellence. Jul 6, 2016 716
Germany : Results of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metastatic Colorectal Cancer. Clinical report Jul 2, 2016 556
Results of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metastatic Colorectal Cancer. Clinical report Jul 1, 2016 1788
Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres Y-90 resin microspheres, New SIRFLOX Analysis Shows. Jul 1, 2016 2020
Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres Y-90 resin microspheres, New SIRFLOX Analysis Shows. Jul 1, 2016 2026
Results of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metastatic Colorectal Cancer. Clinical report Jul 1, 2016 1792
Targeted therapy and immunotherapy may benefit patients with leptomeningeal metastases from melanoma. Shepphird, Jennifer Jul 1, 2016 454
Can lymphovascular invasion replace the prognostic value of lymph node involvement in patients with upper tract urothelial carcinoma after radical nephroureterectomy? Yoo, Eun Sang; Ha, Yun-Sok; Lee, Jun Nyung; Kim, Bum Soo; Kim, Bup Wan; Byun, Seok-Soo; Choi, Young Clinical report Jul 1, 2016 5380
Chemotherapy research for metastatic prostate cancer. Kapoor, Anil; Hotte, Sebastien J. Report Jul 1, 2016 3137
Radionuclides. Kapoor, Anil; Hotte, Sebastien J. Report Jul 1, 2016 1417
NAPOLI-1 Data Demonstrates ONIVYDE Regimen Maintains Quality of Life While Improving Overall Survival in Patients with Metastatic Pancreatic Cancer. Jun 30, 2016 3210
United States : Updated Findings from KEYNOTE-012 for KEYTRUDA (pembrolizumab) Show Continued Benefit in Response Rates and Duration of Response Lasting Up to 30 Months in Patients with Previously Treated Recurrent or Metastatic Head and Neck Cancer. Jun 8, 2016 932
United States : Pivotal Avelumab Study shows Positive Results in Metastatic Merkel Cell Carcinoma. Jun 7, 2016 659
Final Analysis of First-in-Human Phase 1 Study of MM-151 Shows Positive Clinical Activity in Multiple Solid Tumor Types, Including Colorectal Cancer. Jun 6, 2016 1632
First prospective clinical utility trial using comprehensive liquid biopsy to guide metastatic cancer patients to molecularly matched therapies demonstrates comparable results to tissue-based testing. Jun 6, 2016 689
Mutated Gene Influencing Metastatic Colorectal Cancer Survival Rate, According to PiscoMed's Journal AMOR. Jun 3, 2016 822
Malignant transformation of a high-grade osteoblastoma of the petrous apex with subcutaneous metastasis. Kraft, Casey T.; Morrison, Robert J.; Arts, H. Alexander Clinical report Jun 1, 2016 2207
Pelvic limb amputation for the treatment of a soft-tissue sarcoma of the tibiotarso-tarsometatarsal joint in a blue-and-gold macaw (Ara ararauna). Summa, Noemie; Boston, Sarah; Eshar, David; Lee-Chow, Bridget; Harrison, Erin; Fischer, Catherine; J Report Jun 1, 2016 3538
AstraZeneca to offer treatment options to postmenopausal women with HR+ locally-advanced or metastatic breast cancer upon successful Phase III FALCON trial. May 30, 2016 300
AstraZeneca to offer treatment options to postmenopausal women with HR+ locally-advanced or metastatic breast cancer upon successful Phase III FALCON trial. May 30, 2016 296
Merrimack and Baxalta Announce Initiation of Phase 1 Study of MM-151 in Combination with the ONIVYDE (irinotecan liposome injection) Regimen in Metastatic Colorectal Cancer. May 19, 2016 1477
Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy. May 19, 2016 1243
PDA_TGFb: TGF-beta mediated crosstalk between cancer (stem) cells and tumor microenvironment in pancreatic cancer metastasis. May 12, 2016 371
People in Sweden, Denmark and Finland with Advanced Liposarcoma Now Able to Access Halaven (Eribulin), First-ever Treatment to Prolong Overall Survival in Rare and Aggressive Cancer. May 9, 2016 1557
Hutchison China MediTech has initiated an open-label Phase II trial to evaluate the efficacy and safety of sulfatinib (HMPL-012) in patients with locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (DTC). May 1, 2016 159
Retrospective audit: does prior assessment by oral and maxillofacial surgeons reduce the risk of osteonecrosis of the jaw in patients receiving bone-targeted therapies for metastatic cancers to the skeleton?--Part II. Turner, Bruce; Ali, Sacha; Pati, Jhumur; Nargund, Vinod; Ali, Enamul; Cheng, Leo; Wells, Paula Report May 1, 2016 4029
Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy. Song, Yan; Du, Chun-Xia; Zhang, Wen; Sun, Yong-Kun; Yang, Lin; Cui, Cheng-Xu; Chi, Yihe-Bali; Shou, Report May 1, 2016 3152
Renal cell carcinoma extending to the inferior vena cava: a single center surgical experience. Sayyad, Ahmed J. Al; Algarni, Kamal S.; Jabbad, Husain H. Report May 1, 2016 2409
Sentinel lymph node identification by blue dye in patients with breast carcinoma. Apr 30, 2016 2671
Patients with Advanced Metastatic Colorectal Cancer in Europe Now Have New Treatment Option as LONSURF (R) (trifluridine/tipiracil) Receives EU Approval. Apr 28, 2016 2275
Phase III TAILOR Landmark Study Demonstrates Significant Benefits of Erbitux in Combination with FOLFOX Over FOLFOX Alone. Apr 25, 2016 1585
Phase III TAILOR Landmark Study Demonstrates Significant Benefits of Erbitux in Combination with FOLFOX Over FOLFOX Alone. Apr 25, 2016 1633
The study of cutaneous manifestations of malignant diseases. Sangameshwara, G.M.; Venkatesh, U.; Indudhara P.B.; Ganga, H.; Lohith, S. Report Apr 25, 2016 1809
Merck passes conditional approval for KEYTRUDA for the treatment of metastatic non-small cell lung cancer (NSCLC) in Canada. Apr 21, 2016 360
Merck passes conditional approval for KEYTRUDA for the treatment of metastatic non-small cell lung cancer (NSCLC) in Canada. Apr 21, 2016 356
United States : More Than Three Percent of Men on Active Surveillance for Prostate Cancer May Have Metastases. Apr 12, 2016 664
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy Test for Colorectal Cancer Patients. Apr 7, 2016 1783
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients. Apr 6, 2016 1787
New Liquid Biopsy RAS Testing for Metastatic Colorectal Cancer Patients Now Available for Clinical Practices. Apr 6, 2016 1653
New Liquid Biopsy RAS Testing for Metastatic Colorectal Cancer Patients Now Available for Clinical Practices. Apr 6, 2016 1659
Halaven (Eribulin) Receives Positive CHMP Opinion in Advanced Liposarcoma Following Significant Phase III Data. Apr 3, 2016 1969
Taiho's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Phase III TERRA Study in Asian Patients with Refractory Metastatic Colorectal Cancer. Report Apr 1, 2016 1834
United States : Tagrisso (osimertinib) approved in Japan for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer. Mar 30, 2016 496
United States : XALKORI Approved by U.S. FDA for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer. Mar 14, 2016 514
A simple prognostic model for overall survival in metastatic renal cell carcinoma. Assi, Hazem I.; Patenaude, Francois; Toumishey, Ethan; Ross, Laura; Abdelsalam, Mahmoud; Reiman, Ton Clinical report Mar 1, 2016 4738
Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone. Saad, Fred; Winquist, Eric; Hubay, Stacey; Berry, Scott; Assi, Hazem; Levesque, Eric; Aucoin, Nathal Clinical report Mar 1, 2016 6460
Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma. Chang, Ming-Chu; Chang, Yu-Ting; Chen, Jia-Yang; Jeng, Yung-Ming; Yang, Ching-Yao; Tien, Yu-Wen; Yan Report Mar 1, 2016 6256
Malignant melanoma of the oral cavity. Vishnu, Prasad K.P.; Kamath, Panduranga Mulky; Shenoy, Vijendra; Rao, Raghavendra; Jayakrishna, Anne Feb 29, 2016 1581
CHMP Issues Positive Opinion for LONSURF(R) (trifluridine/tipiracil) for Refractory Metastatic Colorectal Cancer. Feb 29, 2016 1865
United Kingdom : TAGRISSO (osimertinib) approved in EU as first-in-class treatment for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer. Feb 4, 2016 659
United States : Lynparza (olaparib) granted Breakthrough Therapy designation by US FDA for treatment of BRCA1/2 or ATM gene mutated metastatic Castration Resistant Prostate Cancer. Jan 29, 2016 455
Vectibix (panitumumab) And Best Supportive Care Improves Overall Survival Compared To Best Supportive Care In Chemorefractory KRAS And RAS Wild-Type Metastatic Colorectal Cancer. Jan 23, 2016 3777
OncoGenex Announces Update on Phase 2 Spruce Trial in Previously Untreated Metastatic Non-Small Cell Lung Cancer. Jan 20, 2016 1072
Updated Data Shows ONIVYDE (irinotecan liposome injection) Combination Regimen Increased One Year Survival by 63% in Patients with Metastatic Pancreatic Cancer. Jan 19, 2016 3544
Surgical management of bulky mediastinal metastases in follicular thyroid carcinoma. Adwin, Zainal; Nur, Ayub; Suhaimi, Shahrun; Rahman, Ramzisham Report Jan 1, 2016 1263
Disseminated Kaposi sarcoma with osseous metastases in an HIV-positive patient. Bell, Bruce M., Jr.; Syed, Almas; Carmack, Susanne W.; Thomas, Cody A.; Layton, Kennith F. Clinical report Jan 1, 2016 1092
Metastatic thymoma involving the bone marrow. Dekmezian, Mhair; Wenceslao, Stella; Krause, John R. Clinical report Jan 1, 2016 1792
Merck KGaA, Darmstadt, Germany, and Pfizer have received Breakthrough Therapy designation for avelumab for the treatment of patients with metastatic Merkel cell carcinoma (MCC) who have progressed after at least one previous chemotherapy regimen. Jan 1, 2016 168
Skeletal health Part 1: overview of bone health and management in the cancer setting. Turner, Bruce; Ali, Sucha; Drudge-Coates, Lawrence; Pati, Jhumur; Nargund, Vinod; Wells, Paula Report Jan 1, 2016 4800
Skeletal health Part 2: development of a nurse practitioner bone support clinic for urologic patients. Turner, Bruce; Ali, Sacha; Drudge-Coates, Lawrence; Pati, Jhumur; Nargund, Vinod; Wells, Paula Report Jan 1, 2016 2830
Port-site metastasis after laparoscopic subtotal gastrectomy in gastric cancer: An uncommon case report. Yang, Chien-Yi; Chan, De-Chuan; Yu, Jyh-Cherng; Lu, Huai-En Jan 1, 2016 1429
Histopathological analysis and surgical treatment of breast cancer--our experience/Histopatoloska analiza ihirurski tretman raka dojke--nase iskustvo. Detanac, Dzemail S.; Detanac, Dzenana A.; Ceranic, Avdo; Ceranic, Merima A. Report Jan 1, 2016 3176
The predictive factors for lymph node metastasis in early gastric cancer: A clinical study. Clinical report Dec 31, 2015 2807
INSIGHTEC Announces Continued Success in Securing Positive Coverage Policies Within the Blue Cross Blue Shield Family of Companies for MRgFUS Treatments of Pain Palliation for Bone Metastases. Dec 22, 2015 528
United States : TAGRISSO (osimertinib) receives positive CHMP opinion for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer. Dec 19, 2015 553
Scientists Gain Better Understanding of How Dormant Circulating Tumor Cells in Breast Cancer Become Metastatic in the Brain. Dec 16, 2015 936
Rare but there: male breast cancer. Nagarkar, Raj.; Roy, Sirshendu; Adhav, Aditya; Jadhav, Abhishek; Tondare, Ashutosh Dec 14, 2015 1639
Tumefactive multiple sclerosis masquerading as cancer. Khan, Kamran; Wozniak, Susan E.; Coleman, JoAnn Dec 1, 2015 1745
A study of the recurrence rates in patients with carcinoma anorectum undergoing abdominoperineal resection. Gill, Hardeep Singh; Jain, Puneet; Singh, Anantbir; Jain, Satish Clinical report Nov 23, 2015 6218
Germany : Merck and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma. Nov 19, 2015 481
Germany,United States : Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma. Nov 19, 2015 491
CYTOPRO: Profiling of tumour cells in blood for personalized treatment of metastatic cancer. Oct 26, 2015 381
Burden of illness of bone metastases in prostate cancer patients in Quebec, Canada: a population-based analysis. Perrault, Louise; Fradet, Vincent; Lauzon, Veronique; LeLorier, Jacques; Mitchell, Dominic; Habib, M Oct 1, 2015 5920
Cytotoxic and Genotoxic biomonitering in patients exposed to radiation therapy a cytological study. Sushma, Susik M.; Shyam, Prasad Reddy D.; Keerthi, M. Report Oct 1, 2015 1784
Trocar site metastasis following robotic oophorectomy for ovarian cancer: a case report and review of the literature. Gauthier, Jason M.; Hauch, Adam; Duong, Buu T.; Crawford, Byron E.; Robinson, William R.; Kandil, Em Clinical report Sep 1, 2015 1730
Comparison of Therapeutic Efficacy between Gastrectomy with Transarterial Chemoembolization Plus Systemic Chemotherapy and Systemic Chemotherapy Alone in Gastric Cancer with Synchronous Liver Metastasis. Liu, Sen-Feng; Lu, Can-Rong; Cheng, Hai-Dong; Xi, Hong-Qing; Cui, Jian-Xin; Li, Ji-Yang; Shen, Wei-S Report Aug 20, 2015 3951
Diplomat to introduce IRESSA as a first-line treatment for selected patients with metastatic non-small cell lung cancer. Aug 11, 2015 261
Diplomat to introduce IRESSA as a first-line treatment for selected patients with metastatic non-small cell lung cancer. Aug 11, 2015 257
Celsion and myTomorrows Expand ThermoDox European Early Access Program to Include Patients with Primary Liver Cancer and Liver Cancer Metastases. Aug 10, 2015 1196
Metastatic Cancer Research Studies Should Better Evaluate and Communicate Quality of Life Measures. Aug 6, 2015 560
Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma. Iacovelli, Roberto; Santini, Daniele; Rizzo, Mimma; Felici, Alessandra; Santoni, Matteo; Verzoni, El Report Aug 1, 2015 3478
Metastatic renal cell cancer: summary from ASCO 2015. Conference notes Aug 1, 2015 2447
Third-line treatment in metastatic renal cell carcinoma and bone metastases. Heng, Daniel Y.C. Viewpoint essay Aug 1, 2015 667
Experimental Computed Tomography-guided Vena Cava Puncture in Pigs for Percutaneous Brachytherapy of Middle Mediastinal Lymph Node Metastases. Zhao, Min; Liu, Bin; Li, Sheng-Yong; Wang, Yong-Zheng; Li, Yu-Liang; Hertzanu, Yancu Report Aug 1, 2015 3040
FDA Grants Breakthrough Therapy Designation to Eisai's Lenvatinib for the Potential Treatment of Metastatic Renal Cell Carcinoma. Jul 28, 2015 2024
INSIGHTEC Announces That Blue Cross Blue Shield (BCBS) Have Approved Additional Positive Coverage Policies for MRgFUS Treatments of Pain Palliation for Bone Metastases in 18 U.S. States. Jul 16, 2015 541
Elbit Imaging Ltd. Announces That InSightec Announces that Additional BCBS Plans Have Published Positive Coverage Policies for MRgFUS Treatments in the Treatment of Pain Palliation for Bone Metastases. Jul 14, 2015 702
miROMeS: miRNA biomarkers of Osseous Metastases in Serum from breast cancer patients. Jul 1, 2015 322
CAPTURE-CTC: A Streptavidin Microarray Platform for Capturing of Circulating Tumor Cells from the Blood of Cancer Patients. Jun 29, 2015 369
Clinical Care Options Releases Report on Critical Practice Gaps in Care of Metastatic Breast Cancer. Jun 22, 2015 777
Results From Phase 3 Trial Show Vectibix (Panitumumab) Improves Overall Survival In Chemorefractory Wild-Type KRAS Metastatic Colorectal Cancer Versus Best Supportive Care. Jun 18, 2015 3245
Clinical Experts Report on How Varian Technology Can Be Used for the Precise, Noninvasive, Simultaneous Treatment of Multiple Metastases in the Brain, Spine, Head & Neck, and Lung. Jun 9, 2015 987
The action of hyperthermia in metastatic colorectal cancer in combination with chemotherapy. Mandraveli, E.; Theodosopoulou, E.; Pistofidis, A.; Alexandratou, K.; Alexandratos, A.; Xatzopoulou, Report Jun 1, 2015 6616
Port site metastasis in prostate cancer. De Bruyne, Peter; Schatteman, Peter; De Naeyer, Geert; Carpentier, Paul; Mottrie, Alex Clinical report Jun 1, 2015 1641
Combination of Novartis drugs Tafinlar and Mekinist shows significant survival benefit in patients with metastatic melanoma. May 31, 2015 3066
Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients. Clinical report May 31, 2015 1433
PharmaEngine Announces Filing New Drug Application (NDA) of MM-398 (PEP02) to Taiwan FDA as a Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer. May 31, 2015 725
PROCLAIM(SM) Patient Registry Data Demonstrates Safety and Efficacy of Proleukin (aldesleukin) When Sequenced with Immune Checkpoint Inhibitors in Metastatic Melanoma. May 28, 2015 1638
PROCLAIM Patient Registry Data Demonstrate Survival Benefit of First-line Proleukin Therapy in Patients with Metastatic Renal Cell Carcinoma. May 28, 2015 1468
Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma. Clinical report May 26, 2015 2265
New Data Show Proleukin (aldesleukin) Improves Patient Outcomes as First-Line Therapy for the Treatment of Patients with Metastatic Melanoma or Metastatic Renal Cell Carcinoma. Clinical report May 15, 2015 1526
Differential proteomic analysis on the effects of 2-methoxy-1,4-naphthoquinone towards MDA-MB-231 cell line. Liew, Kitson; Yong, Phelim Voon Chen; Navaratnam, Visweswaran; Lim, Yang Mooi; Ho, Anthony Siong Hoc Report May 15, 2015 9848
New Data from IMAGE 1 Show Improved Survival in Metastatic Pancreatic Cancer in Patients Receiving IMM-101. Clinical report May 14, 2015 835
Volumetric assessment of lymph node metastases in patients with non-seminomatous germ cell tumours treated with chemotherapy. Basilio-de-Leo, Carlos I.; Villeda-Sandoval, Christian I.; Culebro-Garcia, Carolina; Rodriguez-Covar Report May 1, 2015 3411
Cryoport Supports NeoStem's Intus Study for the Treatment of Metastatic Melanoma. Apr 29, 2015 968
Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer. Apr 20, 2015 1490
Elbit Imaging Ltd. Announces That Insightec Announces BCBS North Carolina and Horizon BCBS of New Jersey Published Positive Coverage of MRgFUS Treatments for Pain Palliation of Bone Cancer Metastases. Apr 16, 2015 678
European Commission Approves Amgen's Vectibix (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer. Apr 6, 2015 2497
Rare case of colonic metastasis. Vinod, Kumar B.; Gatty, Rohan C.; Matthias, Sheldon G.; Martis, John Joseph S. Clinical report Apr 2, 2015 799
Biomarker Testing Before First Line Therapy Key to Improving Survival Rates for Patients Newly Diagnosed With Metastatic Colorectal Cancer. Mar 24, 2015 1385
Thyroid malignancies: a prospective study in a rural teaching Medical College Hospital. Anantharamakrishnan, R.; Kumar, K. Senthil Mar 9, 2015 2376
Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options. Feb 26, 2015 1364
Cancer pain management: role of intrathecal alcohol: a case report. Singh, K. Upendra; Singh, Kh. Lokeshwar; Singh, S. Thoibahenba; Charan, N.; Kay, Jonan Puni Feb 16, 2015 1534
Amgen Announces FDA Advisory Committees To Review Talimogene Laherparepvec For The Treatment Of Patients With Metastatic Melanoma. Feb 11, 2015 2024
Palliative endoscopic surgery for sinonasal metastases: a case report and literature review. Roberts, Jason M.; Brook, Christopher; Parnes, Steven Brief article Feb 1, 2015 117
Basaloid squamous cell carcinoma of the sinonasal tract with metastasis to the liver: a case report and literature review. Toe, Boon Ping; Ramli, Norlisah; Lam, Sze Yin; Wong, Kum Thong; Prepageran, Narayanan Case study Feb 1, 2015 184
An unusual case of penile metastases from Osteosarcoma of femur. Kamoji, Sushruth G.; Arunkumar, S.; Shariff, V.N.S. Ahamed Clinical report Jan 12, 2015 1128
Metastatic pancreatic neuroendocrine tumor with ectopic adrenocorticotropic hormone production. Vaduganathan, Muthiah; Nagarur, Amulya; Kerr, Darcy A.; Lauter, Kelly B.; Padmanabhan, Arun; Raghava Report Jan 1, 2015 2444
Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery. Dec 22, 2014 917
Halaven (Eribulin) in Combination with Capecitabine Provides Clinical Benefit for Women with Metastatic Breast Cancer. Dec 9, 2014 2687
Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib. Richter, Suzanne; Seah, Jo-An; Pond, Gregory R.; Gan, Hui K.; Mackenzie, Mary J.; Hotte, Sebastien J Report Dec 1, 2014 3357
InSightec Invites RSNA 2014 Attendees to Learn About its MR-Guided Focused Ultrasound Solution for Treatment of Uterine Fibroids and Alleviation of Pain Caused by Bone Metastases. Nov 25, 2014 544
Zytiga is Currently the Most Commonly Prescribed Second-Line Therapy for Metastatic Castrate-Resistant Prostate Cancer, According to Surveyed European Oncologists. Nov 18, 2014 728
Prognostic factors for overall survival with targeted therapy in Chinese patients with metastatic renal cell carcinoma. Zhao, Juping; Huang, Xin; Sun, Fukang; Ma, Renyi; Wang, Haofei; Shao, Kun; Zhu, Yu; Zhou, Wenlong; X Report Nov 1, 2014 4856
Circulating tumor cells provide genomic snapshot of breast cancer. Brief article Nov 1, 2014 242
Ante-grade intramedullary nailing for the treatment of humeral shaft metastatic bone tumor. Chen, Jiang-Long; Yeh, Tsu-Te; Pan, Ru-Yu; Wu, Chia-Chun Report Nov 1, 2014 2541
United Kingdom : Xtandi (Enzalutamide) capsules receive positive CHMP opinion for the treatment of men with metastatic castration-resistant prostate cancer who are chemotherapy-naive. Oct 28, 2014 295
CyberKnife Treatment Helps Metastatic Breast Cancer Patient. Oct 21, 2014 574
Evaluation of gall bladder carcinoma by ultrasonography and computed tomography & its comparison: A study of 50 cases. Deka, Nabanita; Goswami, Gautam; Hazarika, Manoj; Bharati, Ashok Oct 9, 2014 2849
InSightec Announces HCSC Positive Coverage Decision for its MRgFUS Procedure for Pain Palliation of Bone Cancer Metastases. Oct 6, 2014 555
Elbit Imaging Ltd. Announces That InSightec Announces HCSC Positive Coverage Decision For Its ExAblate Procedure For Pain Palliation Of Bone Cancer Metastases. Oct 5, 2014 687
United Kingdom : GSK announces overall survival results from phase III BREAK-3 study of Tafinlar(dabrafenib) in patients with BRAF V600E-mutant metastatic melanoma. Clinical report Sep 30, 2014 447
RENAL CELL CARCINOMA METASTASIZING TO PAROTID GLAND. Report Sep 30, 2014 1444
SIR-Spheres Y-90 Resin Microspheres Recommended in New European Society of Medical Oncology (ESMO) Clinical Guidelines for Treating Metastatic Colorectal Cancer (mCRC). Sep 29, 2014 811
SIR-Spheres y-90 Resin Microspheres Recommended in New European Society of Medical Oncology (ESMO) Clinical Guidelines for Treating Metastatic Colorectal Cancer (mCRC). Sep 29, 2014 892
Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer. Sep 16, 2014 784
Eli Lilly and Company's ramucirumab meets primary endpoint of overall survival in metastatic colorectal cancer patients. Clinical report Sep 15, 2014 235
Eli Lilly and Company's ramucirumab meets primary endpoint of overall survival in metastatic colorectal cancer patients. Clinical report Sep 15, 2014 239
Amgen submits talimogene laherparepvec's MAA for approval in the EU for treating metastatic melanoma. Sep 3, 2014 202
Amgen submits talimogene laherparepvec's MAA for approval in the EU for treating metastatic melanoma. Sep 3, 2014 198
Using molecular profiling diagnostics to identify predictive biomarkers in metastatic cancer. Van Tine, Brian A. Report Sep 1, 2014 1679
A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer. Clayton, Ravinder; Wu, Jackson; Heng, Daniel Y.; North, Scott A.; Emmenegger, Urban; Hotte, Sebastie Report Sep 1, 2014 3507
Study Shows that RapidArc Radiosurgery Substantially More Efficient and Comparable in Quality to Gamma Knife in the Treatment of Multiple Brain Metastases. Jul 30, 2014 1328
In vivo and in vitro anti-tumor and anti-metastasis effects of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinoma. Luo, Ke-Wang; Yue, Grace Gar-Lee; Ko, Chun-Hay; Lee, Julia Kin-Ming; Gao, Si; Li, Long-Fei; Li, Gang Report Jul 15, 2014 6786
Ossifying fibromyxoid tumor metastatic to the thyroid: a case report and review of the literature. Lastra, Ricardo R.; Newman, Jason G.; Brooks, John S.; Huang, Jui-Han Case study Jun 1, 2014 1660
Amgen Highlights Phase 2 Results Of Vectibix (panitumumab) Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer. May 31, 2014 2354
PROCLAIM(SM) National Patient Registry Analysis Shows Improved Median Overall Survival in Patients with Metastatic Melanoma Treated with High-Dose Interleukin-2 (HD IL-2). May 31, 2014 1551
PROCLAIM(SM) Patient Registry Data Show Extension of Overall Survival Benefits Beyond Complete and Partial Responders in Metastatic Renal Cell Carcinoma Patients Treated with High-Dose Interleukin-2 (HD IL-2). May 30, 2014 1916
Surveyed Oncologists Indicate Delayed Disease Progression is Among One of the Greatest Unmet Needs in First-Line Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer. May 28, 2014 669
Studies Show that GenomeDx Biosciences' Decipher Test is a Better Predictor of Metastatic Prostate Cancer than Existing Tools. May 20, 2014 950
Germany : Merck Announces New Retrospective Analysis Shows Significant Clinical Benefit in Overall Survival for Metastatic Colorectal Cancer Patients with RAS Wild-Type Tumors Receiving Erbitux plus F. May 17, 2014 264
Merck Announces New Retrospective Analysis Shows Significant Clinical Benefit in Overall Survival for Metastatic Colorectal Cancer Patients with RAS Wild-Type Tumors Receiving Erbitux plus FOLFIRI. May 15, 2014 1704
Taiho Oncology's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Global Phase III RECOURSE Trial in Refractory Metastatic Colorectal Cancer. May 12, 2014 1091
Taiho Oncology's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Global Phase III RECOURSE Trial in Refractory Metastatic Colorectal Cancer. May 12, 2014 1084
New Chemotherapy Combination Extends Survival For Metastatic Pancreatic Cancer By Nearly Two Months. May 1, 2014 762
Cutaneous metastasis of colon cancer: case report and literature review. Sheets, Nicholas; Powers, Jeremy; Richmond, Bryan Clinical report May 1, 2014 1571
Thought Leaders are Optimistic that Emerging Therapies will Offer Efficacy Benefits Over Current Therapies for Metastatic Gastric Cancer; Augmenting Biomarker-Driven Prescribing. Apr 10, 2014 553
Cover the company%s genomic tests for breast cancer patients and patients with metastatic disease. Apr 10, 2014 126
Amgen Provides Update On Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma. Apr 4, 2014 1866
Astellas Announces European Regulatory Submission For XTANDI (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer. Apr 3, 2014 1256
Germany : Bayer Initiates Phase III Trial of Radium-223 Dichloride in Combination with Abiraterone Acetate for Patients with Metastatic Castration-Resistant Prostate Cancer. Apr 3, 2014 425
Taiho's Lonsurf(R) (trifluridine and tipiracil hydrochloride) Tablets Approved In Japan for Treatment of Advanced Metastatic Colorectal Cancer. Mar 24, 2014 576
Taiho's Lonsurf (R) (trifluridine and tipiracil hydrochloride) Tablets Approved in Japan for Treatment of Advanced Metastatic Colorectal Cancer. Mar 24, 2014 573
Germany : PTPSMETBC: Roles of SHP2 and other protein tyrosine phosphatases in metastatic breast cancer. Mar 18, 2014 363
SWITZERLAND - Roles of SHP2 and other protein tyrosine phosphatases in metastatic breast cancer. (PTPSMETBC). Mar 3, 2014 362
Molecular testing as a tool for the management of metastatic cancer patients. Cherkis, Karen Ann; Schroeder, Brock E. Report Mar 1, 2014 3592
Primary testicular carcinoid tumour with mature teratoma in undescended testis metastatic to lymph nodes. Kim, Jae Heon; Noh, Tae Il; Shim, Ji Sung; Ham, Byeong Kuk; Choi, Hoon; Bae, Jae Hyun; Park, Jae You Clinical report Mar 1, 2014 1923
Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib. Iacovelli, Roberto; Cartenì, Giacomo; Milella, Michele; Berardi, Rossana; Di Lorenzo, Giusep Report Mar 1, 2014 3029
A rare case of testicular metastasis of bladder transitional cell carcinoma. Turo, Rafal; Smolski, Michal; Hatimy, Umi; Bromage, Stephen J.; Brown, Stephen C.W.; Brough, Richard Clinical report Mar 1, 2014 1308
Eisai Announces Initiation of a Phase 3 Trial of Eribulin Mesylate Injection Versus Weekly Paclitaxel in First and Second Lines of Metastatic Breast Cancer. Feb 27, 2014 1485
Independent Study Demonstrates Effectiveness of KivaSystem for Patients With Osteolytic Vertebral Metastases. Clinical report Feb 25, 2014 824
Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with TDM-1 in Patients with Metastatic HER2+ Breast Cancer. Feb 20, 2014 1482
Bayer Initiates Phase III Trial of Stivarga (regorafenib) Tablets in Patients with Colorectal Cancer after Resection of Liver Metastases. Feb 20, 2014 2241
Enzo Biochem's unit to distribute Nuclea's HER-2/neu serum test for metastatic breast cancer. Feb 19, 2014 166
BioTheranostics launches panel of genomic-based tests for metastatic cancer. Feb 4, 2014 144
Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with Capecitabine and/or Trastuzumab in Patients with Metastatic HER2+ Breast Cancer. Feb 3, 2014 1618
Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis for BEACON Pivotal Phase 3 Clinical Study in Patients with Metastatic Breast Cancer. Clinical report Jan 14, 2014 2102
Synta Pharmaceuticals Corp to start pan-European Study of ganetespib in p53 mutant, metastatic ovarian cancer patients. Jan 10, 2014 233
Synta Pharmaceuticals Corp to start pan-European Study of ganetespib in p53 mutant, metastatic ovarian cancer patients. Jan 10, 2014 229
Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up. Markou, Athina; Yousef, George M.; Stathopoulos, Efstathios; Georgoulias, Vassilis; Lianidou, Evi Report Jan 1, 2014 5563
Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients. Ramirez, Jean-Marie; Fehm, Tanja; Orsini, Mattea; Cayrefourcq, Laure; Maudelonde, Thierry; Pantel, K Report Jan 1, 2014 5333
Carcinoma en cuirasse. Clinical report Dec 31, 2013 806
European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors. Dec 23, 2013 1305
European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors. Dec 23, 2013 1308
At Twelve Months Post-Launch, the Majority of Surveyed Oncologists Have Prescribed Xtandi to Their Docetaxel-Pretreated Metastatic Castrate-Resistant Prostate Cancer Patients. Dec 9, 2013 708
A phase I dose-escalation study of oral BR-DIM (bioresponse 3,3'- diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Dec 1, 2013 347
Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer. Dec 1, 2013 144
Celgenea[euro](tm)s ABRAXANE receives positive CHMP opinion in combination with Gemcitabine for treating metastatic pancreatic cancer. Nov 25, 2013 215
Celgenea[euro](tm)s ABRAXANE receives positive CHMP opinion in combination with Gemcitabine for treating metastatic pancreatic cancer. Nov 25, 2013 219
Merck Serono Announces CHMP Positive Opinion to Update Erbitux Metastatic Colorectal Cancer Labeling to Patients with RAS Wild-type Tumors. Nov 22, 2013 1232

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters